Violich Capital Management, Inc. Amgen Inc Transaction History

Violich Capital Management, Inc.

$769 Million
Q3 2024

A detailed history of Violich Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Violich Capital Management, Inc. holds 12,030 shares of AMGN stock, worth $3.49 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

12,030

Previous 12,030 -0.0%

Holding current value

$3.49 Million

Previous $3.76 Million 3.11%

% of portfolio

0.5%

Previous 0.51%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $67,217 - $81,140	250 Added 2.12%	12,030 $3.42 Million
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $639,250 - $721,150	-2,500 Reduced 17.51%	11,780 $3.39 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $68,709 - $87,303	-300 Reduced 2.06%	14,280 $3.75 Million
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $101,007 - $113,917	-450 Reduced 2.99%	14,580 $3.29 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $692,130 - $770,220	-3,000 Reduced 16.64%	15,030 $3.66 Million
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $13,156 - $14,554	-60 Reduced 0.33%	18,030 $4.36 Million
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $525,043 - $600,864	-2,640 Reduced 12.74%	18,090 $4.07 Million
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $21,227 - $24,870	-100 Reduced 0.48%	20,730 $4.41 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $16,350 - $18,139	-70 Reduced 0.33%	20,830 $5.08 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $77,668 - $90,510	-350 Reduced 1.65%	20,900 $5.2 Million
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Reduced 0.93%	21,250 $5.4 Million
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $939,597 - $1.15 Million	-4,750 Reduced 18.13%	21,450 $5.06 Million
Q4 2019 Jan 16, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 0.38%	26,200 $6.32 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $366,327 - $438,936	-2,104 Reduced 7.41%	26,300 $5.09 Million
Q2 2019 Jul 22, 2019	SELL	$166.7 - $195.41 $75,015 - $87,934	-450 Reduced 1.56%	28,404 $0
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $18,087 - $20,388	-100 Reduced 0.35%	28,854 $5.48 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $26,760 - $31,237	-150 Reduced 0.52%	28,954 $5.64 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $4,632 - $5,222	-25 Reduced 0.09%	29,104 $6.03 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $22,416 - $25,178	-135 Reduced 0.46%	29,129 $5.38 Million
Q4 2017 Mar 01, 2018	SELL	$168.79 - $188.59 $43,885 - $49,033	-260 Reduced 0.88%	29,264 $5.09 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $25,260 - $28,841	-151 Reduced 0.51%	29,524 $5.51 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,675	29,675 $0

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.

Account

Violich Capital Management, Inc. Amgen Inc Transaction History